ホーム › 卵巣がん › カリフォルニア州 › Orange
Orange、CAにおける卵巣がんの臨床試験
Orangeとその周辺地域（約30マイル以内）の拠点で、卵巣がんに関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
被験者募集中第2/3相
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
被験者募集中第2相
- Children's Hospital of Orange County, Orange
- Saint Joseph Hospital - Orange, Orange
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
被験者募集中第1/2相
- Chao Family Comprehensive Cancer Center, Orange
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- UC IRVINE Health, Orange
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
被験者募集中第1相
- University of California Irvine Medical Center, Orange
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
被験者募集中第3相
- Uci Health Chao Family Comprehensive Cancer Center, Orange
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
被験者募集中第3相
- UCI Health Chao Family Comprehensive Cancer Center, Orange
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
被験者募集中第1/2相
- Children's Hospital of Orange County, Orange
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
被験者募集中
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
被験者募集中第1/2相
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
被験者募集中第1/2相
- Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
被験者募集中第2相
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
被験者募集中第1/2相
- UC Irvine Health-Chao Family Comprehensive Cancer Center, Orange
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
被験者募集中第2相
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
被験者募集中早期第1相
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Orange
他の都市における卵巣がんの試験
- Houston, TX89件の研究
- New York City, NY69件の研究
- Boston, MA61件の研究
- Los Angeles, CA50件の研究
- Nashville, TN49件の研究
- Arlington, VA46件の研究
- Philadelphia, PA44件の研究
- Columbus, OH39件の研究
- St. Louis, MO38件の研究
- Chicago, IL36件の研究
- San Antonio, TX31件の研究
- Cleveland, OH30件の研究
Orangeにおける他の研究
- 非小細胞肺癌25件の研究
- 転移性癌20件の研究
- 大腸癌16件の研究
- 膵臓がん15件の研究
- 悪性黒色腫14件の研究
- 肝臓がん（肝細胞がん）14件の研究
- 乳がん14件の研究
- 肺がん14件の研究
- 前立腺がん14件の研究
- 胃癌13件の研究
- がん（全種類）13件の研究
- 急性骨髄性白血病13件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。